Literature DB >> 22317842

Thrombotic microangiopathies: from empiricism to targeted therapies.

Paul Coppo1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22317842     DOI： 10.1016/j.lpm.2011.10.023

Source DB:  PubMed          Journal:  Presse Med        ISSN： 0755-4982            Impact factor:   1.228


× No keyword cloud information.
  3 in total

1.  TMA secondary to SLE: rituximab improves overall but not renal survival.

Authors:  Fangfang Sun; Xiaodong Wang; Wanlong Wu; Kaiwen Wang; Zhiwei Chen; Ting Li; Shuang Ye
Journal:  Clin Rheumatol       Date:  2017-08-30       Impact factor: 2.980

2.  EB virus reactivation triggers thrombotic thrombocytopenic purpura in a healthy adult.

Authors:  Satoko Oka; Masaharu Nohgawa
Journal:  Leuk Res Rep       Date:  2017-06-20

3.  Epidemiology, treatment patterns, clinical outcomes, and disease burden among patients with immune-mediated thrombotic thrombocytopenic purpura in the United States.

Authors:  Ayoade Adeyemi; Francesca Razakariasa; Alexandra Chiorean; Rui de Passos Sousa
Journal:  Res Pract Thromb Haemost       Date:  2022-09-16
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.